SAB Biotherapeutics, Inc.
USD3.48
+0.04 (+1.16%)
CEO
Samuel J. Reich
IPO Date
2021-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.50
Prev. Close
$3.44
Day Low
$3.41
Day High
$3.54
52W Low
$1.60
52W High
$6.60
Market Cap
$0.03B
Volume
0.46M
| 3,000,000 |
| $4.45 |
| 5 Feb 2026 | Reich Samuel J | director, officer: CEO | A-Award | Acquired | 4,800,000 | $4.45 |
| 5 Feb 2026 | Bausch Christoph Lawrence | CHIEF OPERATING OFFICER | A-Award | Acquired | 1,800,000 | $4.45 |
| 5 Feb 2026 | Kropotova Alexandra | CHIEF MEDICAL OFFICER | A-Award | Acquired | 2,400,000 | $4.45 |
| 5 Feb 2026 | To Lucy | See Remarks | A-Award | Acquired | 2,400,000 | $4.45 |
| 7 Jan 2026 | Jain Rita | director | A-Award | Acquired | 240,000 | $3.74 |
| 7 Jan 2026 | ZACCARDELLI DAVID | director | A-Award | Acquired | 240,000 | $3.74 |
| 7 Jan 2026 | Jain Rita | — | Disposed | 0 | $0.00 |
| 7 Jan 2026 | ZACCARDELLI DAVID | — | Disposed | 0 | $0.00 |